Kingsley Advani

Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio, Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.

Kingsley Advani is the CEO at Allocations, based in United States, North America. With a background in Financial Services, Kingsley Advani has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.